Investor Alert: Class Actions Initiated for Methode Electronics, DexCom, Endava, and Orthofix

NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- In a critical reminder issued to shareholders, the law firm Bragar Eagel & Squire, P.C., known for championing shareholder rights, has announced the initiation of class action lawsuits concerning several prominent public companies. This legal pursuit represents the interests of investors in electronics manufacturer Methode Electronics MEI, medical device company Orthofix Medical OFIX, diabetes management technology firm DexCom DXCM, and IT and consulting services provider Endava DAVA.

Methode Electronics, Inc. MEI

Methode Electronics MEI, with headquarters in Chicago, Illinois, is recognized for its international presence in designing, manufacturing, and marketing critical component devices as well as subsystems utilized across various industries. The company's products play a foundational role in enhancing the efficiency and dependability of electronic apparatuses globally.

DexCom, Inc. DXCM

DexCom DXCM, headquartered in San Diego, California, and with a manufacturing base in Mesa, Arizona, stands out as a leader in the medical technology space. Its cutting-edge continuous glucose monitoring (CGM) systems are pivotal in the diabetes management sector, offering innovative solutions for ongoing glucose level assessments critical to patient care.

Endava plc DAVA

Headquartered in London, Endava DAVA constitutes a powerhouse in technology services. Catering to diverse sectors such as consumer products, healthcare, logistics, and retail, the company boasts a broad geographical footprint, serving clients in Europe, Latin America, and North America with its advanced technology solutions.

Orthofix Medical Inc. OFIX

Orthofix Medical OFIX, based in Lewisville, Texas, operates extensively within the realm of medical devices and biological products. With a presence in several crucial global markets including the United States, Italy, Germany, the United Kingdom, and Brazil, the company dedicates its resources to the development and distribution of a wide array of medical apparatuses esteemed for their therapeutic value.

As these class action suits progress, Bragar Eagel & Squire, P.C. encourages investors of MEI, DXCM, DAVA, and OFIX to step forward and contact the firm to assert their rights and potentially secure compensatory solutions for any financial grievances incurred as shareholders.

lawsuit, investor, reminder